← Back
Data updated: Mar 29, 2026
CARNEGIE
OncologyGastroenterologyDermatology
Generics
CARNEGIE is a generic drug manufacturer focused on Oncology, Gastroenterology, Dermatology.
1965
Since
14
Drugs
-
Trials
77
Approved (2yr)
Key Drugs
No active drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 20%
2 drugs
Gastroenterology 20%
2 drugs
Dermatology 20%
2 drugs
Neurology 20%
2 drugs
Immunology 20%
2 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Competitors by Therapeutic Area
Pfizer big-pharma
Oncology, Dermatology, Immunology, Gastroenterology
Eli Lilly big-pharma
Oncology, Immunology, Neurology, Dermatology
Bristol-Myers Squibb big-pharma
Oncology, Immunology, Gastroenterology, Neurology
Takeda big-pharma
Immunology, Oncology, Gastroenterology, Neurology
AbbVie big-pharma
Immunology, Oncology, Neurology
Active (8)
Discontinued (6)
Company Info
- First Approval
- 1965-04-02
- Latest
- 2025-10-27
- Applications
- 13